Page last updated: 2024-08-24

irinotecan and DIPG Brain Tumors

irinotecan has been researched along with DIPG Brain Tumors in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Browd, SR; Cole, BL; Crotty, EE; Ellenbogen, RG; Ermoian, RP; Geyer, JR; Hauptman, JS; Leary, SES; Lee, A; Lockwood, CM; Millard, NE; Ojemann, JG; Olson, JM; Paulson, VA; Sato, AA; Vitanza, NA	1

Other Studies

1 other study(ies) available for irinotecan and DIPG Brain Tumors

Article	Year
Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience. Journal of neuro-oncology, 2020, Volume: 148, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Stem Neoplasms; Child; Child, Preschool; Diffuse Intrinsic Pontine Glioma; Female; Follow-Up Studies; Glioma; Humans; Infant; Irinotecan; Male; Neoplasm Grading; Retrospective Studies; Survival Rate; Temozolomide	2020

Article

Year

Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.

Journal of neuro-oncology, 2020, Volume: 148, Issue:3

Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Stem Neoplasms; Child; Child, Preschool; Diffuse Intrinsic Pontine Glioma; Female; Follow-Up Studies; Glioma; Humans; Infant; Irinotecan; Male; Neoplasm Grading; Retrospective Studies; Survival Rate; Temozolomide

2020